BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 1319061)

  • 1. Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7.
    Beutner U; Frankel WN; Cote MS; Coffin JM; Huber BT
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5432-6. PubMed ID: 1319061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mls-1-like superantigen in the MA/MyJ mouse is encoded by a new mammary tumor provirus that is distinct from Mtv-7.
    Rudy CK; Kraus E; Palmer E; Huber BT
    J Exp Med; 1992 Jun; 175(6):1613-21. PubMed ID: 1316931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of mouse mammary tumor virus-induced T cell responses in vivo by antibodies to an open reading frame protein.
    Acha-Orbea H; Scarpellino L; Shakhov AN; Held W; MacDonald HR
    J Exp Med; 1992 Dec; 176(6):1769-72. PubMed ID: 1334118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7).
    Held W; Shakhov AN; Waanders G; Scarpellino L; Luethy R; Kraehenbuhl JP; MacDonald HR; Acha-Orbea H
    J Exp Med; 1992 Jun; 175(6):1623-33. PubMed ID: 1316932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The open reading frames in the 3' long terminal repeats of several mouse mammary tumor virus integrants encode V beta 3-specific superantigens.
    Pullen AM; Choi Y; Kushnir E; Kappler J; Marrack P
    J Exp Med; 1992 Jan; 175(1):41-7. PubMed ID: 1309854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of Mls-1.
    Beutner U; Rudy C; Huber BT
    Int Rev Immunol; 1992; 8(4):279-88. PubMed ID: 1318934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. V beta 17 T-cell deletion by endogenous mammary tumor virus in wild-type-derived mouse strain.
    Jouvin-Marche E; Cazenave PA; Voegtle D; Marche PN
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3232-5. PubMed ID: 1314381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and characterization of an Mls-1-specific monoclonal antibody.
    Mohan N; Mottershead D; Subramanyam M; Beutner U; Huber BT
    J Exp Med; 1993 Feb; 177(2):351-8. PubMed ID: 8381154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delay in expression of a mammary tumor provirus is responsible for defective clonal deletion during postnatal period.
    Niimi N; Wajjwalku W; Ando Y; Tomida S; Takeuchi M; Ueda M; Kaneda T; Yoshikai Y
    Eur J Immunol; 1994 Feb; 24(2):488-91. PubMed ID: 8299700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus.
    Waanders GA; Shakhov AN; Held W; Karapetian O; Acha-Orbea H; MacDonald HR
    J Exp Med; 1993 May; 177(5):1359-66. PubMed ID: 8386743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue distribution of Mtv-7-like exogenous retroviral transcripts and clonal deletion of V beta 6+ T cells in Mls-1b BALB/c mice.
    Desaymard C; Tucek CL; Rocha B; Korman AJ; Papiernik M
    Int Immunol; 1993 Feb; 5(2):217-22. PubMed ID: 8383996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous superantigen expression is controlled by mouse mammary tumor proviral loci.
    Woodland DL; Lund FE; Happ MP; Blackman MA; Palmer E; Corley RB
    J Exp Med; 1991 Nov; 174(5):1255-8. PubMed ID: 1658187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T cells respond to mouse mammary tumor virus-encoded superantigen: V beta restriction and conserved evolutionary features.
    Labrecque N; McGrath H; Subramanyam M; Huber BT; Sékaly RP
    J Exp Med; 1993 Jun; 177(6):1735-43. PubMed ID: 8388432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells.
    Foo-Phillips M; Kozak CA; Principato MA; Abe R
    J Immunol; 1992 Dec; 149(11):3440-7. PubMed ID: 1331236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel V beta 2-specific endogenous mouse mammary tumor virus which is capable of producing a milk-borne exogenous virus.
    Niimi N; Wajjwalku W; Ando Y; Nakamura N; Ueda M; Yoshikai Y
    J Virol; 1995 Nov; 69(11):7269-73. PubMed ID: 7474151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mls, Mtv, and T cells: possible roles in retroviral diseases.
    Macphail S
    Cancer Cells; 1991 Aug; 3(8):312-4. PubMed ID: 1657087
    [No Abstract]   [Full Text] [Related]  

  • 18. Divergent viral superantigens delete V beta 5+ T lymphocytes.
    Gollob KJ; Palmer E
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):5138-41. PubMed ID: 1317583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus.
    Choi Y; Kappler JW; Marrack P
    Nature; 1991 Mar; 350(6315):203-7. PubMed ID: 1706480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mouse mammary tumour virus long terminal repeat encodes a type II transmembrane glycoprotein.
    Korman AJ; Bourgarel P; Meo T; Rieckhof GE
    EMBO J; 1992 May; 11(5):1901-5. PubMed ID: 1316276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.